LYKALABS logo

Lyka Labs Limited Stock Price

NSEI:LYKALABS Community·₹3.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LYKALABS Share Price Performance

₹84.38
-62.28 (-42.47%)
₹84.38
-62.28 (-42.47%)
Price ₹84.38

LYKALABS Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

2 Risks
0 Rewards

Lyka Labs Limited Key Details

₹1.3b

Revenue

₹556.1m

Cost of Revenue

₹777.0m

Gross Profit

₹757.6m

Other Expenses

₹19.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.54
58.28%
1.45%
30.4%
View Full Analysis

About LYKALABS

Founded
1976
Employees
499
CEO
Kunal Gandhi
WebsiteView website
www.lykalabs.com

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

Recent LYKALABS News & Updates

Recent updates

No updates